drugset / Trial / NCT00933920

Effect of Light Meal on Pharmacokinetic and Pharmacodynamics of Aliskiren in Patients With Mild to Moderate Hypertension

NCT00933920

Phase 1 Completed 124 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupSingle-blindBasic science

Summary

The purpose of this study is to determine the effect of a light meal on the pharmacokinetics and pharmacodynamics of aliskiren in patients with mild to moderate hypertension.

Timeline

Start
2009-06
Primary completion
2009-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aliskiren Small molecule

Indications